Skip to main content

Sandercock Brett's Form 4 filing

Resmed Inc (RMD) · filed Jul 2, 2025

Accession no.
0000943819-25-000025
Filed
Jul 2, 2025
Trade date
Jul 1, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $997.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sandercock BrettCIK 0001346064Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2025ResMed Common StockMOption exerciseAcquired+1,966$101.64+$199,824.2487,249Direct
Jul 1, 2025ResMed Common StockMOption exerciseAcquired+917$101.64+$93,203.8888,166Direct
Jul 1, 2025ResMed Common StockSSaleDisposed−3,883$256.99−$997,892.1784,283Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 1, 2025ResMed Common StockMOption exerciseDisposed−1,966$0.00$08,917Direct
Jul 1, 2025ResMed Common StockMOption exerciseDisposed−917$0.00$08,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)